Massive study digs into cancer treatment failures in poorer nations
NCT ID NCT07246213
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will look back at the medical records of 18,000 children, teens, and young adults with cancer treated in five low- and middle-income countries. The goal is to measure how often treatment fails or causes serious side effects, especially for leukemia and lymphoma. No new drugs or treatments are being tested — instead, researchers hope to find patterns that can guide future efforts to improve care in places where resources are limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could identify key barriers and gaps in cancer care in low-resource settings, pointing toward practical interventions to improve survival.
- What could go wrong
- This is a retrospective chart review, not a treatment trial. It cannot prove what works, only describe what happened. Results may not apply to other regions or hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fundación Ayúdame a Vivir
NOT_YET_RECRUITINGEl Salvador, El Salvador, 1101, El Salvador
-
Hospital Escuela
NOT_YET_RECRUITINGTegucigalpa, Distrito Central, 11101, Honduras
-
Hospital Mario Catarino Rivas
NOT_YET_RECRUITINGSan Pedro Sula, Cortés Department, 21102, Honduras
-
Unidad Nacional de Oncología Pediátrica (UNOP)
RECRUITINGGuatemala City, Guatemala
-
Yeolyan Center for Cancer and Blood Disorders
RECRUITINGYerevan, Armenia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Can donor immune cells tame stem cell transplant risks?
- A simple blood draw could spare kids with leukemia from painful bone marrow tests
- Fighting sedentary time in young cancer patients: a digital intervention put to the test